RUBY
Rubius Therapeutics, Inc
RUBY
RUBY
Delisted
RUBY was delisted on the 6th of March, 2023.
105 hedge funds and large institutions have $1.55B invested in Rubius Therapeutics, Inc in 2021 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 36 increasing their positions, 33 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
26% less capital invested
Capital invested by funds: $2.09B → $1.55B (-$541M)
Holders
105
Holding in Top 10
3
Calls
$3.1M
Puts
$1.15M
Top Buyers
| 1 | +$21.5M | |
| 2 | +$4.27M | |
| 3 | +$3.69M | |
| 4 |
Two Sigma Advisers
New York
|
+$1.99M |
| 5 |
Two Sigma Investments
New York
|
+$1.75M |
Top Sellers
| 1 | -$8.55M | |
| 2 | -$2.88M | |
| 3 | -$2.85M | |
| 4 |
Voloridge Investment Management
Jupiter,
Florida
|
-$2.21M |
| 5 |
EGI
EAM Global Investors
Solana Beach,
California
|
-$1.83M |